Literature DB >> 22054876

Lung cancer: epidemiology, etiology, and prevention.

Charles S Dela Cruz1, Lynn T Tanoue, Richard A Matthay.   

Abstract

Lung cancer is the leading cause of cancer death in the United States and around the world. A vast majority of lung cancer deaths are attributable to cigarette smoking, and curbing the rates of cigarette smoking is imperative. Understanding the epidemiology and causal factors of lung cancer can provide additional foundation for disease prevention. This article focuses on modifiable risk factors, including tobacco smoking, occupational carcinogens, diet, and ionizing radiation. It also discusses briefly the molecular and genetic aspects of lung carcinogenesis. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22054876      PMCID: PMC3864624          DOI: 10.1016/j.ccm.2011.09.001

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  259 in total

1.  Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Authors:  Daphne W Bell; Ira Gore; Ross A Okimoto; Nadia Godin-Heymann; Raffaella Sordella; Roseann Mulloy; Sreenath V Sharma; Brian W Brannigan; Gayatry Mohapatra; Jeff Settleman; Daniel A Haber
Journal:  Nat Genet       Date:  2005-10-30       Impact factor: 38.330

2.  The global burden of disease due to occupational carcinogens.

Authors:  Timothy Driscoll; Deborah Imel Nelson; Kyle Steenland; James Leigh; Marisol Concha-Barrientos; Marilyn Fingerhut; Annette Prüss-Ustün
Journal:  Am J Ind Med       Date:  2005-12       Impact factor: 2.214

3.  Fatty foods and the risk of lung cancer: a case-control study from Uruguay.

Authors:  E De Stefani; E T Fontham; V Chen; P Correa; H Deneo-Pellegrini; A Ronco; M Mendilaharsu
Journal:  Int J Cancer       Date:  1997-05-29       Impact factor: 7.396

4.  Lung cancer mortality among nonsmoking uranium miners exposed to radon daughters.

Authors:  R J Roscoe; K Steenland; W E Halperin; J J Beaumont; R J Waxweiler
Journal:  JAMA       Date:  1989-08-04       Impact factor: 56.272

5.  Lower lung cancer mortality in obesity.

Authors:  Chi C Leung; Tai H Lam; Wing W Yew; Wai M Chan; Wing S Law; Cheuk M Tam
Journal:  Int J Epidemiol       Date:  2010-08-12       Impact factor: 7.196

6.  Asbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality study.

Authors:  J M Hughes; H Weill
Journal:  Br J Ind Med       Date:  1991-04

7.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

8.  Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution.

Authors:  C Arden Pope; Richard T Burnett; Michael J Thun; Eugenia E Calle; Daniel Krewski; Kazuhiko Ito; George D Thurston
Journal:  JAMA       Date:  2002-03-06       Impact factor: 56.272

9.  Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.

Authors:  Gerardo Heiss; Robert Wallace; Garnet L Anderson; Aaron Aragaki; Shirley A A Beresford; Robert Brzyski; Rowan T Chlebowski; Margery Gass; Andrea LaCroix; JoAnn E Manson; Ross L Prentice; Jacques Rossouw; Marcia L Stefanick
Journal:  JAMA       Date:  2008-03-05       Impact factor: 56.272

10.  Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies.

Authors:  Zheng Ye; Honglin Song; Julian P T Higgins; Paul Pharoah; John Danesh
Journal:  PLoS Med       Date:  2006-03-07       Impact factor: 11.069

View more
  383 in total

Review 1.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

2.  Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.

Authors:  T Powrózek; P Krawczyk; M Nicoś; B Kuźnar-Kamińska; H Batura-Gabryel; J Milanowski
Journal:  Clin Transl Oncol       Date:  2015-08-27       Impact factor: 3.405

3.  Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy.

Authors:  Jessica R Glover; Frank O Velez-Cubian; Wei Wei Zhang; Kavian Toosi; Tawee Tanvetyanon; Emily P Ng; Carla C Moodie; Joseph R Garrett; Jacques P Fontaine; Eric M Toloza
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

Review 4.  The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease.

Authors:  Sharon L I Wong; Maria B Sukkar
Journal:  Br J Pharmacol       Date:  2016-11-25       Impact factor: 8.739

5.  Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.

Authors:  Claudia Stumpf; Daniel Kaemmerer; Elisa Neubauer; Jörg Sänger; Stefan Schulz; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-03       Impact factor: 4.553

6.  Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.

Authors:  Patrick H Lizotte; Elena V Ivanova; Mark M Awad; Robert E Jones; Lauren Keogh; Hongye Liu; Ruben Dries; Christina Almonte; Grit S Herter-Sprie; Abigail Santos; Nora B Feeney; Cloud P Paweletz; Meghana M Kulkarni; Adam J Bass; Anil K Rustgi; Guo-Cheng Yuan; Donald W Kufe; Pasi A Jänne; Peter S Hammerman; Lynette M Sholl; F Stephen Hodi; William G Richards; Raphael Bueno; Jessie M English; Mark A Bittinger; Kwok-Kin Wong
Journal:  JCI Insight       Date:  2016-09-08

7.  CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer.

Authors:  Yong Bai; Guojun Zhang; Ruirui Cheng; Rui Yang; Heying Chu
Journal:  Cell Cycle       Date:  2019-08-05       Impact factor: 4.534

8.  New benzenesulphonohydrazide derivatives as potential antitumour agents.

Authors:  Łukasz Popiołek; Monika Gawrońska-Grzywacz; Anna Berecka-Rycerz; Kinga Paruch; Iwona Piątkowska-Chmiel; Dorota Natorska-Chomicka; Mariola Herbet; Anna Gumieniczek; Jarosław Dudka; Monika Wujec
Journal:  Oncol Lett       Date:  2020-09-02       Impact factor: 2.967

Review 9.  Lung cancer epidemiology: contemporary and future challenges worldwide.

Authors:  Joanna Didkowska; Urszula Wojciechowska; Marta Mańczuk; Jakub Łobaszewski
Journal:  Ann Transl Med       Date:  2016-04

10.  Long non-coding RNA ZEB2-AS1 promotes proliferation and inhibits apoptosis in human lung cancer cells.

Authors:  Yang Guo; Ying Hu; Mingming Hu; Jiabei He; Baolan Li
Journal:  Oncol Lett       Date:  2018-02-01       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.